Standard
New Research Reveals Immune System’s Role in Alzheimer’s Brain Damage, Offering Potential New Treatment Path
For decades, the scientific community has been locked in a high-stakes race to identify the primary drivers of neurodegeneration in Alzheimer’s disease. While the accumulation of amyloid plaques and tau protein tangles has long been the primary focus of drug development, a groundbreaking study from the Washington University School of Medicine in St. Louis suggests…
